Stock Information
Merck & Co Inc (MRK)
Ticker Symbol: MRK
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $249,078,941,800.00 mil
Piotroski score: 8
PE Ratio: 13.1821
EPS (TTM): 7.5607
Revenue (TTM): $25.71 M
Dividend Yield: 3.3767006%
ROE: 38.95%
Latest News
-
This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter
Fri, Dec 19, 2025 5:06 PM
-
Merck (MRK)’s CEO Has a “Better Hand,” Says Jim Cramer
Fri, Dec 19, 2025 2:50 PM
-
Jim Cramer Couldn’t Stop Gushing About Johnson & Johnson (JNJ)’s Cancer Drugs
Fri, Dec 19, 2025 2:50 PM
-
Nine of the largest pharma companies ink deals with Trump to lower drug prices
Fri, Dec 19, 2025 2:32 PM
-
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
Fri, Dec 19, 2025 12:00 PM
-
Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes
Fri, Dec 19, 2025 12:25 AM
-
BMO Capital Upgrades Merck (MRK)
Fri, Dec 19, 2025 12:05 AM
-
Merck (MRK) Rises Higher Than Market: Key Facts
Thu, Dec 18, 2025 10:50 PM
-
Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case
Thu, Dec 18, 2025 10:47 PM
-
Does Merck KGaA’s Rebound Reflect Its True Value After AI Partnership And CEO Change News
Thu, Dec 18, 2025 8:13 PM
Key Financials
Financial data not available
